Clinical Trial Search

Primary: Trough Forced Expiratory Volume in One Second (FEV1) at Day 28 of the Relevant Treatment Period — 2.605; 2.714; 2.703; 2.693 Liters — p=<0.001

Primary: Change in Forced Expiratory Volume in 1 Second (FEV1) From Baseline at Two Hours After Inhalation of the Study Medication — 84; 52 mL — p=0.17

Primary: Mean Aqueous Humor Concentration of Moxifloxacin — 1110.6 nanograms per milliliter

Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 12 — 77.18; 58.46; 63.33; -26.29 unit on a scale

Primary: Difference in Incidence of Cognitive Impairment Between Groups. Change Between Preoperative and Postoperative Cognitive Function Was Assessed by Performing Standardized…

Primary: Number of Patients With Adverse Events (AEs) — 103; 377; 8; 35 participants

Primary: PK Substudy - Area Under the Curve of Albendazole in Treatment in Day 1 — 1412.2; 1111 ng*h/mL

Primary: Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) — -22; 0; -17; 0 percent change

Primary: Delayed Graft Function — 8; 12 participants

Primary: Tolerability Rate — 60 percentage of participants

Primary: Area Under the Curve (AUC) of the Numeric Rating Scale at Rest (NRS-R) Pain Intensity Scores — 359; 396 Units on a scale*hours

Primary: Mean Depression Rating Using the Hospital Anxiety and Depression Scale (HADS) — 22.08; 24.45 units on a scale — p=0.171

Primary: Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) With Activity (NRS-A) Pain Intensity Scores Through Postoperative Day 4 — 20.4; 20.7; 19.5; 18.8 Units on a…

Primary: The Area Under the Curve (AUC) of the Numeric Rating Scale at Rest (NRS-R) Pain Intensity Scores Through 72 Hours for Subjects Receiving SKY0402 vs. Placebo. — 141.8…

Primary: Area Under the Concentration-time Curve of Linagliptin in Plasma Over the Time Interval 0 to 72 Hours (AUC0-72) — 248; 251; 266; 264 nmol*h/L